LeMaitre Vascular, a provider of disposable and implantable peripheral vascular devices, has acquired the Lifespan Vascular Graft manufacturing business from Angiotech Pharmaceuticals, for $2.8m in exchange for the business, which includes a factory located in Laguna Hills, California.

Lifespan is a vascular prosthesis used in the repair or replacement of diseased arteries and in the creation of vascular access sites for dialysis.

Lifespan was introduced in the mid-1990s and is currently sold in the US, the European Union, Japan, Canada, and several other markets through third-party distributors, primarily Edwards Lifesciences.

In a related transaction, LeMaitre Vascular and Edwards have agreed to a wind-down of Edwards’ distribution of Lifespan, which is scheduled to conclude on 30 November 2010.

LeMaitre Vascular will pay Edwards $0.75m in exchange for orderly market transitions in Europe (where Lifespan sales are strongest) and Japan, and will pay approximately $0.5m for the majority of Edwards’ inventory.

The company will also receive the Lifespan trademark from Edwards.

LeMaitre Vascular intends to begin selling Lifespan through its own worldwide sales force on 1 December 2010.

LeMaitre Vascular develops, manufactures and markets disposable and implantable vascular devices to address the needs of vascular surgeons.